Skip to main content

Table 4 Unadjusted and adjusted hazard ratios of the association between clinical characteristics and 1-year mortality

From: Long-term outcomes in patients who received veno-venous extracorporeal membrane oxygenation and renal replacement therapy: a retrospective cohort study

Characteristic

Univariate analysis

Multivariable modela

Hazard ratio

95% CI

P-value

Adjusted hazard ratio

95% CI

P-value

AKI/RRT group

 No AKI

1 (reference)

–

–

1 (reference)

 AKI without RRT

0.57

0.22, 1.46

0.241

 AKI with RRT

2.01

1.15, 3.51

0.014

1.80

1.06, 3.06

0.029

Age (per 5 years)

1.10

1.01, 1.19

0.022

1.06

0.98, 1.15

0.171

Female sex

1.00

0.64, 1.56

0.988

   

BMI (per kg/m2)

0.98

0.95, 1.02

0.335

   

Chronic liver disease

3.71

1.61, 8.55

0.002

4.36

1.83, 10.4

< 0.001

Malignancy

5.98

3.15, 11.4

< 0.001

7.68

3.95, 14.9

< 0.001

SOFA score on admission

1.08

1.02, 1.14

0.009*

   

Diabetes

1.41

0.78, 2.56

0.253

   

Hypertension

1.28

0.74, 2.21

0.384

   

Congestive heart failure

0.41

0.06, 2.92

0.371

   

CKD

0.50

0.07, 3.56

0.485

   

Coronary artery disease

1.42

0.45, 4.50

0.551

   

Atrial fibrillation

1.90

0.47,7.73

0.371

   

Cerebrovascular accidents

1.23

0.30, 5.02

0.770

   

Chronic lung disease

0.71

0.40, 1.25

0.232

   

Infectious vs. non-infectious aetiology

0.85

0.53, 1.37

0.503

0.62

0.38, 1.01

0.054

Baseline serum albumin on admission (per 10 g/L)

0.57

0.35, 0.91

0.018

0.55

0.32, 0.95

0.031

  1. RRT renal replacement therapy, BMI body mass index, SOFA Sequential Organ Failure Assessment, CKD chronic kidney disease, ECMO extracorporeal membrane oxygenation, HR hazard ratio, CI confidence interval
  2. *SOFA score not selected for multivariable analysis due to the collinearity with RRT status
  3. aMultivariable model includes RRT status (as a time-dependent covariate), age, chronic liver disease, malignancy, infectious vs. non-infectious aetiology and baseline serum albumin